These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 7026328)
21. Kinetic analysis of the response of plasma glucose, insulin, and C-peptide to glucagon injection in normal and diabetic subjects. Turco G; Brossa C; D'Alberto M; Regis G; Segre G; Bianchi E; Bruni B; Gamba S Diabetes; 1981 Aug; 30(8):685-93. PubMed ID: 7018972 [TBL] [Abstract][Full Text] [Related]
22. Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels. Paolisso G; Sgambato S; Passariello N; Scheen A; D'Onofrio F; Lefèbvre PJ Diabetes; 1987 May; 36(5):566-70. PubMed ID: 2883055 [TBL] [Abstract][Full Text] [Related]
23. A high concentration of circulating insulin suppresses the glucagon response to hypoglycemia in normal man. Liu D; Moberg E; Kollind M; Lins PE; Adamson U J Clin Endocrinol Metab; 1991 Nov; 73(5):1123-8. PubMed ID: 1682339 [TBL] [Abstract][Full Text] [Related]
24. Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients. Toft-Nielsen MB; Madsbad S; Holst JJ Diabetes Care; 1999 Jul; 22(7):1137-43. PubMed ID: 10388979 [TBL] [Abstract][Full Text] [Related]
25. Effect of metformin on blood glucose, insulin and C-peptide responses to glucagon in non-insulin dependent diabetics. Ferlito S; Del Campo F; Di Vincenzo S; Damante G; Coco R; Branca S; Fichera C Farmaco Sci; 1983 Apr; 38(4):248-54. PubMed ID: 6345193 [TBL] [Abstract][Full Text] [Related]
26. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients. Creutzfeldt WO; Kleine N; Willms B; Orskov C; Holst JJ; Nauck MA Diabetes Care; 1996 Jun; 19(6):580-6. PubMed ID: 8725855 [TBL] [Abstract][Full Text] [Related]
28. Failure of indomethacin to affect arginine-induced C-peptide and glucagon release in insulin-treated diabetics. Major role of residual B cell function in conditioning the magnitude of the blood glucose rise after intravenous arginine. Luyckx AS; Mendoza E; Lefebvre PJ Diabetologia; 1981 Oct; 21(4):376-82. PubMed ID: 7026333 [TBL] [Abstract][Full Text] [Related]
32. Effects of insulin on the response of immunoreactive glucagon to an intravenous glucose load in human diabetes. Yamamoto T; Raskin P; Aydin I; Unger R Metabolism; 1979 May; 28(5):568-74. PubMed ID: 449698 [TBL] [Abstract][Full Text] [Related]
33. The inhibitory effect of somatostatin on growth hormone, insulin and glucagon secretion in diabetes mellitus. Ward FR; Leblanc H; Yen SS J Clin Endocrinol Metab; 1975 Sep; 41(3):527-32. PubMed ID: 1159060 [TBL] [Abstract][Full Text] [Related]
34. Serum magnesium in insulin-dependent diabetics and healthy subjects in relation to insulin secretion and glycemia during glucose-glucagon test. Menzel R; Pusch H; Ratzmann GW; Besch W; Förster F; Albrecht G; Ruhnke R Exp Clin Endocrinol; 1985 Feb; 85(1):81-8. PubMed ID: 3886415 [TBL] [Abstract][Full Text] [Related]
35. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man. Rizza R; Verdonk C; Miles J; Service FJ; Gerich J J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838 [TBL] [Abstract][Full Text] [Related]
36. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes. Shilo S; Sotsky M; Shamoon H J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178 [TBL] [Abstract][Full Text] [Related]
37. The effect of hyperglucagonaemia on blood glucose concentrations and on insulin requirements during fasting in insulin dependent diabetes mellitus. Clarke WL; Melton TW; Bright GM Acta Endocrinol (Copenh); 1983 Apr; 102(4):557-60. PubMed ID: 6342325 [TBL] [Abstract][Full Text] [Related]
38. Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamide. Frier BM; Ashby JP; Nairn IM; Baird JD Diabete Metab; 1981 Mar; 7(1):45-9. PubMed ID: 7016620 [TBL] [Abstract][Full Text] [Related]
39. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans. Vella A; Shah P; Reed AS; Adkins AS; Basu R; Rizza RA Diabetologia; 2002 Oct; 45(10):1410-5. PubMed ID: 12378382 [TBL] [Abstract][Full Text] [Related]
40. Glucose, insulin, and glucagon levels during exercise in pancreas transplant recipients. Redmon JB; Kubo SH; Robertson RP Diabetes Care; 1995 Apr; 18(4):457-62. PubMed ID: 7497853 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]